Results

Total Results: 2,504 records

Showing results for "anxiety".

1281. Paramedics and the effects of shift work on sleep: a literature review. | PSNet
      psnet.ahrq.gov/issue/paramedics-and-effects-shift-work-sleep-literature-review
      July 24, 2017 - October 5, 2022 Maths anxiety and medication dosage calculation errors: a scoping review

1282. The association between EMS workplace safety culture and safety outcomes. | PSNet
      psnet.ahrq.gov/issue/association-between-ems-workplace-safety-culture-and-safety-outcomes
      November 10, 2010 - 2018 Emergency medical services responders' perceptions of the effect of stress and anxiety

1283. Patient safety in obstetrics: what aviators, firefighters and others can teach us. | PSNet
      psnet.ahrq.gov/issue/patient-safety-obstetrics-what-aviators-firefighters-and-others-can-teach-us
      January 22, 2017 - 2018 Emergency medical services responders' perceptions of the effect of stress and anxiety

1284. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/h8qcZeQ68AQPS9DemArgXX
      July 13, 2021 - For harms (eg, anxiety or worry), the trials reported no significant differences between screening and … not find clinically important differences be- tween the screening and control groups in measures of anxiety … , depression, worry, or self-reported health, but 1 reported short-term increases in anxiety (at 6 weeks … Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety … Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort

1285. Psn-Pdf (pdf file)
      psnet.ahrq.gov/node/49613/psn-pdf
      November 01, 2010 - The risk of high parental anxiety is much greater than the risk of disease transmission from a breast

1286. Vision Screening in Children Aged 6Months to 5 Years: Recommendation Statement (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/wyAJqjxBX_dHMF3WdA7WNt
      September 05, 2017 - accidents and injuries, experiencing bullying behaviors, poor visual motor skills, depression and anxiety … of vision screening in preschool-aged children in­ clude psychosocial effects such as labeling and anxiety … false-positive rates (usually <35%).1 No studies reported measures of psychosocial distress, labeling, or anxiety

1287. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix E (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-ape_0.xlsx
      August 08, 2017 - reduction): RD 0.10 (0.08 to 0.12) Function/disability: -0.21 (-0.26 to -0.16) QoL: -0.20 (-0.25 to -0.15) Anxiety … reduction): RD 0.10 (0.07 to 0.13) Function/disability: -0.16 (-0.22 to -0.10) QoL: -0.19 (-0.25 to -0.12) Anxiety … reduction): 0.11 (0.07 to 0.15) Function/disability: -0.29 (-0.37 to -0.21) QoL: -0.22 (-0.30 to -0.13) Anxiety

1288. Use of mHealth Technology for Supporting Symptom Management in Underserved Persons Living with HIV - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r21hs023963-schnall-final-report-2018.pdf
      January 01, 2018 - group participants showed a significantly greater improvement than the control group in 5 symptoms: anxiety … and relevance of various self-management strategies for symptom management for fatigue, neuropathy, anxiety … Symptoms included: (1) Anxiety, (2) Cough or shortness of breath, (3) Depression, (4) Diarrhea, (5) … 1 Sample self care strategies for 13 symptoms Symptom Example of re-worded self-care strategy Anxiety … Variable Overall Intervention Control Significance N = 80 N = 40 N = 40 (p-value) Anxiety

1289. CDS Repository Working Group Charter (pdf file)
      cds.ahrq.gov/sites/default/files/cds/artifact/476/CDS%20Pain%20Management%20Summary%20Quick%20Start%20Guide_final_1.pdf
      July 23, 2024 - Medical History  Risk factors for Opioid-related Harms: Always flag if any are present (Depression, Anxiety

1290. Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
      February 01, 2019 - Psychological and social effects are also common and can manifest in a number of ways, including depression, anxiety … overall function or disability, and quality of life • Secondary outcomes will include depression, anxiety

1291. Psn-Pdf (pdf file)
      psnet.ahrq.gov/node/851568/psn-pdf
      July 31, 2023 - (0-7) Tremor (0-7) Auditory disturbances (0-7) Paroxysmal sweats (0-7) Visual disturbances (0-7) Anxiety … of dexmedetomidine as an adjunct to benzodiazepine therapy to control autonomic hyperactivity and anxiety

1292. In Conversation With… Susan E. Skochelak, MD, PhD | PSNet
      psnet.ahrq.gov/perspective/conversation-susan-e-skochelak-md-phd
      February 01, 2019 - Anxiety has crept into medical education for them about residency, the match, and future career choice … And that's causing some real anxiety, not just for the students but for the medical educators on both

1293. Archived: Depression in Adults: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/depression-in-adults-screening-2009
      December 15, 2009 - The severity of depression and comorbid psychological problems (for example, anxiety, panic attacks, … unexplained somatic symptoms, comorbid psychological conditions (for example, panic disorder or generalized anxiety

1294. Recommendation: Syphilis Infection During Pregnancy: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-pregnancy-screening
      May 13, 2025 - include false-positive or discordant results from screening that require clinical evaluation, unnecessary anxiety … harms, including false-positive or discordant results that require additional clinical evaluation and anxiety

1295. Archived: Final Evidence Summary: Chlamydial Infection: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary14/chlamydial-infection-screening-2007
      June 15, 2007 - expressed concern over the meaning of their diagnosis to their future fertility and had significant anxiety … These studies find significant anxiety and concern for the future of intimate relationships after a positive

1296. Recommendation: Speech and Language Delay and Disorders in Children: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening
      January 23, 2024 - speech and language delays and disorders in young children in primary care include the time, effort, and anxiety … Studies are needed on the potential harms of screening and treatment such as labeling, stigma, parent anxiety

1297. Screening for Autism Spectrum Disorder in Young Children: USPSTF Recommendation Statement (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/Lm94jySKCYrG3zsUP8Jd8E
      February 16, 2016 - about the harms of screening for ASD in children, reported potential harms include misdiagnosis and the anxiety … Potential harms include misdiagnosis and the time, ef- fort, and anxiety associated with further testing

1298. Recommendation: Illicit Drug Use in Children, Adolescents, and Young Adults: Primary Care-Based Interventions | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-primary-care-interventions-for-children-and-adolescents
      May 26, 2020 - adolescence has been associated with negative psychosocial and neurocognitive effects, including increased anxiety … (5 trials), depression symptoms (7 trials), externalizing (3 trials), internalizing (1 trial), and anxiety

1299. Measuring Safety: A New Perspective on Outcomes of a Long-term Intensive Case Management Program (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Cotayo.pdf
      April 22, 2004 - depression/bipolar disorder (40 percent), attention deficit hyperactivity disorder (11 percent), and anxiety … diagnoses were major depression/ bipolar disorder (39 percent), depressive disorder (11 percent), and anxiety

1300. A Complicated Course: Severe Alcohol Withdrawal with Dexmedetomidine Infusion | PSNet
      psnet.ahrq.gov/web-mm/complicated-course-severe-alcohol-withdrawal-dexmedetomidine-infusion
      June 14, 2023 - disturbances (0-7) Tremor (0-7) Auditory disturbances (0-7) Paroxysmal sweats (0-7) Visual disturbances (0-7) Anxiety … use of dexmedetomidine as an adjunct to benzodiazepine therapy to control autonomic hyperactivity and anxiety